"I have been impressed with PharmaMar's progress to date, and I am honored to join the team at this exciting time as it seeks to build out its U.S. infrastructure and continues to execute against its business objectives and clinical development timelines," Besman said. "PharmaMar has a proven disruptive approach to help cancer patients and I look forward to contributing to the Company's future success as we seek to continue building shareholder value."
CAMBIO DE DISCURSO : LA SECOND-LINE SCLC-ES TRAS EL FIASCO DE LA FASE III LAGOON YA MEJOR NI NOMBRARLA...CAMBIAMOS DISCURSO A MANTENIMIENTO EN FIRTS-LINE Y PASAMOS DEL VIAL DE 4 Mg AI VIAL DE 2 Mg .//. JazzPharma TO WITHDRAW LURBINECTEDIN WITH US_FDA IN SECOND-LINE SCLC-ES...EN ESPAÑA NO SE HAN ENTERADO AÚN...SI NO EXISTIERA IMFORTE...AHORA MISMO PHARMAMAR ESTARÍA ANTE UNA GRAVE SITUACIÓN ... 2 DE OCTUBRE DE 2028 ... ES LA FECHA MÁS TEPMPRANA PARA LA POSIBLE ENTRADA DE GENÉRICOS .
02 enero 2017
PharmaMar Names Besman New Chief Operating Officer .
Dec 31, 2016 .
... Besman's responsibilities will include overseeing the implementation of PharmaMar’s operational infrastructure in the U.S.
"I have been impressed with PharmaMar's progress to date, and I am honored to join the team at this exciting time as it seeks to build out its U.S. infrastructure and continues to execute against its business objectives and clinical development timelines," Besman said. "PharmaMar has a proven disruptive approach to help cancer patients and I look forward to contributing to the Company's future success as we seek to continue building shareholder value."
"I have been impressed with PharmaMar's progress to date, and I am honored to join the team at this exciting time as it seeks to build out its U.S. infrastructure and continues to execute against its business objectives and clinical development timelines," Besman said. "PharmaMar has a proven disruptive approach to help cancer patients and I look forward to contributing to the Company's future success as we seek to continue building shareholder value."